AVTX
Price
$11.60
Change
+$1.44 (+14.17%)
Updated
Sep 5 closing price
Capitalization
152.57M
VTGN
Price
$3.54
Change
-$0.08 (-2.21%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
108.92M
Interact to see
Advertisement

AVTX vs VTGN

Header iconAVTX vs VTGN Comparison
Open Charts AVTX vs VTGNBanner chart's image
Avalo Therapeutics
Price$11.60
Change+$1.44 (+14.17%)
Volume$363.34K
Capitalization152.57M
VistaGen Therapeutics
Price$3.54
Change-$0.08 (-2.21%)
Volume$1.92K
Capitalization108.92M
AVTX vs VTGN Comparison Chart in %
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. VTGN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a StrongBuy and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AVTX: $11.60 vs. VTGN: $3.55)
Brand notoriety: AVTX and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 152% vs. VTGN: 55%
Market capitalization -- AVTX: $152.57M vs. VTGN: $108.92M
AVTX [@Biotechnology] is valued at $152.57M. VTGN’s [@Biotechnology] market capitalization is $108.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVTX and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).

  • AVTX’s TA Score: 5 bullish, 4 bearish.
  • VTGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AVTX and VTGN are a good buy in the short-term.

Price Growth

AVTX (@Biotechnology) experienced а +24.87% price change this week, while VTGN (@Biotechnology) price change was +6.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTX($153M) has a higher market cap than VTGN($109M). AVTX YTD gains are higher at: 56.124 vs. VTGN (22.712). VTGN (-58.99M) and AVTX (-59.78M) have comparable annual earnings (EBITDA) . AVTX has more cash in the bank: 113M vs. VTGN (63.2M). AVTX has less debt than VTGN: AVTX (679K) vs VTGN (2.36M). VTGN has higher revenues than AVTX: VTGN (646K) vs AVTX (441K).
AVTXVTGNAVTX / VTGN
Capitalization153M109M140%
EBITDA-59.78M-58.99M101%
Gain YTD56.12422.712247%
P/E Ratio1.77N/A-
Revenue441K646K68%
Total Cash113M63.2M179%
Total Debt679K2.36M29%
FUNDAMENTALS RATINGS
AVTX vs VTGN: Fundamental Ratings
AVTX
VTGN
OUTLOOK RATING
1..100
826
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3638
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (51) in the Biotechnology industry is somewhat better than the same rating for AVTX (85) in the Pharmaceuticals Other industry. This means that VTGN’s stock grew somewhat faster than AVTX’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that VTGN’s stock grew similarly to AVTX’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as AVTX (99) in the Pharmaceuticals Other industry. This means that VTGN’s stock grew similarly to AVTX’s over the last 12 months.

AVTX's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as VTGN (38) in the Biotechnology industry. This means that AVTX’s stock grew similarly to VTGN’s over the last 12 months.

AVTX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for VTGN (100) in the Biotechnology industry. This means that AVTX’s stock grew significantly faster than VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXVTGN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGXXF15.300.06
+0.41%
NGEx Minerals Ltd.
MYNDF0.03N/A
N/A
MYND Life Sciences Inc.
CSYJY3.23N/A
N/A
CSE Global Ltd
LCGMF0.09N/A
-1.63%
LION COPPER & GOLD CORP.
MONRY56.33-1.37
-2.37%
Moncler S.P.A.

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
+14.17%
FGEN - AVTX
57%
Loosely correlated
+6.98%
LIANY - AVTX
39%
Loosely correlated
+0.94%
ALNY - AVTX
30%
Poorly correlated
-0.34%
VTGN - AVTX
30%
Poorly correlated
-1.93%
MGTX - AVTX
29%
Poorly correlated
-0.39%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with COGT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-1.90%
COGT - VTGN
41%
Loosely correlated
-1.07%
IPSC - VTGN
39%
Loosely correlated
+2.26%
IMNM - VTGN
39%
Loosely correlated
-4.39%
CRIS - VTGN
38%
Loosely correlated
-0.58%
SRRK - VTGN
38%
Loosely correlated
-5.64%
More